Changes in the melanocortin receptors in the hypothalamus of a rat model of cancer cachexia

Synapse

Volumn 66, Issue 8, 2012, Pages 747-751

  Suzuki, Masami ^a   Narita, Minoru ^b   Ashikawa, Maho ^b   Furuta, Sadayoshi ^b   Matoba, Motohiro ^c   Sasaki, Hiroki ^a   Yanagihara, Kazuyoshi ^d   Terawaki, Kiyoshi ^a   Suzuki, Tsutomu ^b   Uezono, Yasuhito ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b HOSHI UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER   (Japan)

^d YASUDA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Central melanocortin system; Hypothalamus; Rat; Stage dependent cancer cachexia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MESSENGER RNA; PROOPIOMELANOCORTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACHEXIA; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; WEIGHT REDUCTION;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CACHEXIA; DISEASE MODELS, ANIMAL; HYPOTHALAMUS; MALE; NEOPLASMS; PRO-OPIOMELANOCORTIN; RATS; RECEPTOR, MELANOCORTIN, TYPE 4; RECEPTORS, MELANOCORTIN; RNA, MESSENGER;

EID: 84861716770     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21559     Document Type: Article

References (16)

1. Acharyya S, Butchbach ME, Sahenk Z, Wang H, Saji M, Carathers M, Ringel MD, Skipworth RJ, Fearon KC, Hollingsworth MA, Muscarella P, Burghes AH, Rafael-Fortney JA, Guttridge DC. 2005. Dystrophin glycoprotein complex dysfunction: A regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell 8: 421-432.
2. Balthasar N, Dalgaard LT, Lee CE, Yu J, Funahashi H, Williams T, Ferreira M, Tang V, McGovern RA, Kenny CD, Christiansen LM, Edelstein E, Choi B, Boss O, Aschkenasi C, Zhang CY, Mountjoy K, Kishi T, Elmquist JK, Lowell BB. 2005. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 123: 493-505.
3. Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan XM, Yu H, Rosenblum CI, Vongs A, Feng Y, Cao L, Metzger JM, Strack AM, Camacho RE, Mellin TN, Nunes CN, Min W, Fisher J, Gopal-Truter S, Maclntyre DE, Chen HY, Van der Ploeg LH. 2000. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 26: 97-102.
4. De Jonghe BC, Hayes MR, Bence KK. 2011. Melanocorotin control of energy balance: Evidence from rodent models. Cell Mol Life Sci 68: 2569-2588.
5. Deboer MD, Marks DL. 2006. Cachexia: Lessons from melanocortin antagonism. Trends Endocrinol Metab 17: 199-204.
6. Fearon KC. 2008. Cancer cachexia: Developing multimodal therapy for a multidimensional problem. Eur J Cancer 44: 1124-1132.
7. Garfield AS, Lam DD, Marston OJ, Przydzial MJ, Heisler LK. 2009. Role of central melanocortin pathway in energy homeostasis. Trends Endocrinol Metab 20: 203-215.
8. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F. 1997. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88: 131-141.
9. T) method. Methods 25: 402-408.
10. Muscaritoli M, Anker SD, Argiles J, Aversa Z, Bauer JM, Biolo G, Boirie Y, Bosaeus I, Cederholm T, Costelli P, Fearon KC, Laviano A, Maggio M, RossiFanelli F, Schols A, Sieber CC. 2010. Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics." Clin Nutr 29: 154-159.
11. Norman K, Pichard C, Lochs H, Pirlich M. 2008. Prognostic impact of disease-related malnutrition. Clin Nutr 27: 5-15.
12. Rousso-Noori L, Knobler H, Levy-Apter E, Kuperman Y, Neufeld-Cohen A, Keshet Y, Akepati VR, Klinghoffer RA, Chen A, Elson A. 2011. Protein tyrosine phosphatase epsilon affects body weight by downregulating leptin signaling in a phosphorylation-dependent manner. Cell Metab 13: 562-572.
13. Tisdale M. 2009. Mechanisms of cancer cachexia. Physiol Rev 89: 381-410.
14. Xu B, Goulding EH, Zang K, Cepoi D, Cone RD, Jones KR, Tecott LH, Reichardt LF. 2003. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 6: 763-742.
15. Yanagihara K, Tanaka H, Takigahira M, Ino Y, Yamaguchi Y, Toge T, Sugano K, Hirohashi S. 2004. Establishment of two cell lines from human gastric scirrhous carcinoma that possess the potential to metastasize spontaneously in nude mice. Cancer Sci 95: 575-582.
16. Zimmermann M. 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110.